Scotland’s Synpromics expands gene therapy work with UCL deal – PharmaTimes
PharmaTimes |
Scotland's Synpromics expands gene therapy work with UCL deal
PharmaTimes Edinburgh, Scotland based Synpromics has teamed up with UCL Great Ormond Street Institute of Child Health to develop novel gene therapies for diseases affecting the haematopoietic system. This partnership further expands the firm's activities in the … |
